{"nct_id":"NCT06750094","title":"A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-12-12","start_date_type":"ACTUAL","primary_completion_date":"2027-12-15","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04-13","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}